Partial palivizumab prophylaxis and increased risk of hospitalization due to respiratory syncytial virus in a Medicaid population: a retrospective cohort analysis.

MLA

Krilov, Leonard R., et al. “Partial Palivizumab Prophylaxis and Increased Risk of Hospitalization Due to Respiratory Syncytial Virus in a Medicaid Population: A Retrospective Cohort Analysis.” BMC Pediatrics, vol. 14, Oct. 2014, p. 261. EBSCOhost, https://doi.org/10.1186/1471-2431-14-261.

APA

Krilov, L. R., Masaquel, A. S., Weiner, L. B., Smith, D. M., Wade, S. W., & Mahadevia, P. J. (2014). Partial palivizumab prophylaxis and increased risk of hospitalization due to respiratory syncytial virus in a Medicaid population: a retrospective cohort analysis. BMC Pediatrics, 14, 261. https://doi.org/10.1186/1471-2431-14-261

Chicago

Krilov, Leonard R, Anthony S Masaquel, Leonard B Weiner, David M Smith, Sally W Wade, and Parthiv J Mahadevia. 2014. “Partial Palivizumab Prophylaxis and Increased Risk of Hospitalization Due to Respiratory Syncytial Virus in a Medicaid Population: A Retrospective Cohort Analysis.” BMC Pediatrics 14 (October): 261. doi:10.1186/1471-2431-14-261.